Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer.

Heldin P, Basu K, Olofsson B, Porsch H, Kozlova I, Kahata K

J. Biochem. 154 (5) 395-408 [2013-11-00; online 2013-10-03]

Clinical and experimental data indicate that hyaluronan accumulates in breast cancer compared with normal breast epithelium, which correlates to poor prognosis. In this review, we discuss the expression of genes encoding enzymes that synthesize or degrade hyaluronan, i.e. hyaluronan synthases and hyaluronidases or bind hyaluronan, i.e. CD44 and receptor for hyaluronan-mediated motility (RHAMM, also designated as HMMR or CD168), in relation to breast cancer progression. Hyaluronan and hyaluronan receptors have multi-faceted roles in signalling events in breast cancer. A better understanding of the molecular mechanisms underlying these signalling pathways is highly warranted and may lead to improvement of cancer treatment.

Affiliated researcher

PubMed 24092768

DOI 10.1093/jb/mvt085

Crossref 10.1093/jb/mvt085

pii: mvt085


Publications 7.1.2